Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)

BACKGROUND: How can a clinician and patient incorporate survival and toxicity information into a single expression of comparative treatment benefit? Sloan et al. recently extended the ½ standard deviation concept for judging the clinical importance of findings from clinical trials to survival and tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Major-Elechi, Brittny T., Novotny, Paul J., Singh, Jasvinder A., Bonner, James A., Dueck, Amylou C., Sargent, Daniel J., Grothey, Axel, Sloan, Jeff A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686677/
https://www.ncbi.nlm.nih.gov/pubmed/31396297
http://dx.doi.org/10.6000/1929-6029.2018.07.04.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686677/
https://www.ncbi.nlm.nih.gov/pubmed/31396297
http://dx.doi.org/10.6000/1929-6029.2018.07.04.4

Ejemplares similares